Sen. Maggie Hassan (D-NH) (Photo by Michael Brochstein/Sipa USA)(Sipa via AP Images)
May 1, 2024 03:04 PM EDTUpdated 03:27 PM
Pharma
FDA+

Sen­a­tor al­leges GSK is shirk­ing its com­mit­ment to low­er in­haler costs

Lia DeGroot

Sen. Mag­gie Has­san (D-NH) is pres­sur­ing GSK to put a com­mon­ly used pe­di­atric in­haler back on the mar­ket af­ter the com­pa­ny stopped pro­duc­ing it in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Take­da to pay $200M for rights to ane­mia drug from Keros

Rev­o­lu­tion sells $600M in shares on back of RAS in­hibitor port­fo­lio up­dates

Janux soars on ear­ly prostate can­cer da­ta that could chal­lenge No­var­tis' Plu­vic­to

Roche teams up with Chica­go au­toim­mune biotech COUR Phar­ma­ceu­ti­cals

Ipsen se­cures rights to pre­clin­i­cal T cell en­gager in $610M pact with French biotech

Gilead makes an­oth­er ADC move, ink­ing up to $415M pact with Tubu­lis

A service from the Financial Times